Glycemic Management for High Blood Sugar in Surgical Patients

Recruiting at 1 trial location

Overseen By Shannon M Ruzycki, MD, MPH

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Calgary

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

10000 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial tests a special care plan called PGMP to manage blood sugar in surgical patients at risk of high levels. It aims to improve recovery by monitoring and controlling blood sugar, reducing complications, and shortening hospital stays.

Eligibility Criteria

This trial is for adults over 18 who are undergoing surgery and will be in the hospital for more than a day afterward. It's designed to help those at risk of high blood sugar after their operation, including people with known or undiagnosed diabetes.

Inclusion Criteria

I am an adult who will be in the hospital for more than a day after surgery.

Exclusion Criteria

I am under 18 years old.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation

Implementation of the Perioperative Glycemic Management Pathway (PGMP) in surgical patients to manage postoperative glycemia and improve outcomes

3 months

Regular monitoring visits as per hospital protocol

Follow-up

Participants are monitored for safety and effectiveness after implementation of PGMP, including length-of-stay, readmission rates, and surgical site infections

12 months

Treatment Details

Interventions

• Perioperative glycemic management pathway

Trial Overview The trial tests a Perioperative Glycemic Management Pathway (PGMP) against usual care to see if it can better manage post-surgery blood sugar levels, shorten hospital stays, reduce readmissions, and save costs. The study involves multiple hospitals and uses a stepped-wedge design.

Participant Groups

Group I: Intervention: PGMP Active Control 1 Intervention

Sites will implement a perioperative glycemic management pathway based on national guidelines and current evidence, with support of an implementation scientist team.

Group II: Non-intervention: usual care Active Control 1 Intervention

Sites will perform usual perioperative glycemic management.

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials

827

Recruited

902,000+